1:00 PM - 2:00 PM Eastern
Did you know that 3 million people in the US are affected by Epilepsy, and are likely to have more seizures than individuals without Epilepsy, but also that 1 in 26 people will develop Epilepsy in their lifetime? People whom your agency supports may experience a range of types of seizures that your staff may not notice and may not have the experience to manage. In this webinar, join Jazz Pharmaceuticals to hear and learn directly from representatives of a state agency, a national agency, and a state association. In the panel discussion, each will share how they are effectively educating their team members and stakeholders on seizure identification and seizure control, selection of medications that can be used, and how to engage with a partner to obtain critical education and guidance that can be passed to their team members.
Presenters
- Kathy Carmody, CEO, Institute on Public Policy for People with Disabilities
- Josh DeZurik, Director of Quality Affirmation, Dungarvin
- Jean Gelpi, National Account Executive-IDD Long Term Care, Epilepsy and Movement Disorders Business Unit, Jazz Pharmaceuticals
- Darlene Scott, President & CEO, Phoenix Residence
- Barbara Merrill, CEO, ANCOR (moderator)
| 8/19/2025 |    |